Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response to Pseudoephedrine Concurrent With Placebo or TR 701 FA.

Next Previous
X
Search
Trial Profile

A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response to Pseudoephedrine Concurrent With Placebo or TR 701 FA.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 14 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tedizolid (Primary) ; Pseudoephedrine
  • Indications Bacteraemia; Bacterial infections; Gram-positive infections; Skin and soft tissue infections
  • Focus Pharmacodynamics
  • Sponsors Trius Therapeutics

    • Most Recent Events

    • 12 Jun 2013 Results were published in Antimicrobial Agents and Chemotherapy, according to a Trius Therapeutics media release.
    • 29 Apr 2013 Results presented at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting, according to a Trius Therapeutics media release.
    • 11 Sep 2012 Results will be presented at ICAAC-2012 according to a Trius Therapeutics media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top